Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity

Arthritis and Rheumatology

Volumn 66, Issue 8, 2014, Pages 2037-2046

  Daien, Claire I ^a   Gailhac, Sarah ^b   Mura, Thibault ^c   Audo, Rachel ^b   Combe, Bernard ^a   Hahne, Michael ^b   Morel, Jacques ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b CNRS   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; C REACTIVE PROTEIN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; RHEUMATOID FACTOR; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; REGULATORY INTERLEUKIN 10 PRODUCING B CELL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-10; LYMPHOCYTE COUNT; MALE; MIDDLE AGED;

EID: 84905051610     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38666     Document Type: Article

References (23)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008; 58: 26-35.
2. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
3. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868-78.
4. Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol 2012; 180: 2375-85.
5. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28: 639-50.
6. Klinker MW, Lundy SK,. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 2012; 18: 123-37.
7. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32: 129-40.
8. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH,. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100: 4537-43.
9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
10. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
11. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117: 530-41.
12. Cantaert T, Doorenspleet ME, FrancoSalinas G, Paramarta JE, Klarenbeek PL, Tiersma Y, et al. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum 2012; 64: 1859-68.
13. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF,. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182: 7459-72.
14. + T-cell activation in vitro. Eur J Immunol 2010; 40: 2686-91.
15. H17 differentiation. Sci Transl Med 2013; 5: 173ra23.
16. Aletaha D, Smolen J,. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 Suppl 39: S100-8.
17. Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T, Brown M, et al. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther 2009; 11: R84.
18. Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, et al. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun 2007; 29: 154-63.
19. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, et al. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006; 54: 3799-808.
20. Bucht A, Oksenberg JR, Lindblad S, Gronberg A, Steinman L, Klareskog L,. Characterization of T-cell receptor αβ repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. Scand J Immunol 1992; 35: 159-65.
21. Elewaut D, De Keyser F, Van den Bosch F, Verbruggen G, Veys EM,. Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration. Clin Exp Rheumatol 2000; 18: 201-7.
22. De Paz B, Alperi-Lopez M, Ballina-Garcia FJ, Prado C, Gutierrez C, Suarez A,. Cytokines and regulatory T cells in rheumatoid arthritis and their relationship with response to corticosteroids. J Rheumatol 2010; 37: 2502-10.
23. Ma L, Liu B, Jiang Z, Jiang Y,. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Rheumatol 2014; 33: 187-95.